<?xml version="1.0" encoding="UTF-8"?>
<ref id="B102-vaccines-07-00074">
 <label>102.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Ditse</surname>
    <given-names>Z.</given-names>
   </name>
   <name>
    <surname>Muenchhoff</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>Adland</surname>
    <given-names>E.</given-names>
   </name>
   <name>
    <surname>Jooste</surname>
    <given-names>P.</given-names>
   </name>
   <name>
    <surname>Goulder</surname>
    <given-names>P.</given-names>
   </name>
   <name>
    <surname>Moore</surname>
    <given-names>P.L.</given-names>
   </name>
   <name>
    <surname>Morris</surname>
    <given-names>L.</given-names>
   </name>
  </person-group>
  <article-title>HIV-1 Subtype C-Infected Children with Exceptional Neutralization Breadth Exhibit Polyclonal Responses Targeting Known Epitopes</article-title>
  <source>J. Virol.</source>
  <year>2018</year>
  <volume>92</volume>
  <fpage>e00878-18</fpage>
  <pub-id pub-id-type="doi">10.1128/JVI.00878-18</pub-id>
  <?supplied-pmid 29950423?>
  <pub-id pub-id-type="pmid">29950423</pub-id>
 </element-citation>
</ref>
